Buch, Englisch, 330 Seiten, Format (B × H): 159 mm x 241 mm
Buch, Englisch, 330 Seiten, Format (B × H): 159 mm x 241 mm
ISBN: 978-93-5270-029-5
Verlag: JP Medical
Lipidology is the study of cholesterol, in particular in finding treatments for high cholesterol and other lipid disorders.
This book is a comprehensive guide to lipidology for endocrinologists and trainees.
Divided into four sections, the text begins with an overview of the specialty, followed by discussion on clinical aspects – dietary issues and cardiovascular disease, lipid markers, good cholesterol, lipoproteins and more.
The next section covers therapeutic lipidology, from diet and exercise, to statins, HDL-targeted (high density lipoproteins), and evolving targets such as PCSK9 inhibitors (a type of medicine for lowering cholesterol in the blood).
The final section examines Dyslipidemia (an abnormal amount of lipids in the blood) in specific sectors of the population – children and adolescents, pregnant women, the elderly, in HIV patients, and in patients with chronic kidney disease.
The book is highly illustrated with clinical images and figures to assist learning.
Key points
- Comprehensive guide to lipidology for endocrinologists and trainees
- Covers many therapeutic options including evolving techniques
- Discusses management of Dyslipidemia in specific population sectors
- Highly illustrated with images, diagrams and tables
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
- Section 1: Basic Lipidology
- Human Lipoprotein Metabolism: An Overview
- Lipoproteins: Mechanisms for Atherogenesis
- Apolipoprotein B Particles and Cardiovascular Disease
- Lipoprotein (a): An Update
- Monogenic Lipoprotein Disorders: The Phenotype to Genotype
- Section 2: Clinical Lipidology
- Dietary Fats and Cardiovascular Disease
- Dyslipidemia: Relationship to Insulin Resistance, Fatty Liver, and Sub-Clinical Atherosclerosis
- Risk Assessment of Different Lipid Markers: Clinical Appraisal and Goal of Therapy
- Rethinking Good Cholesterol: Understanding the Role of HDL
- Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
- Non-HDL is a Better Marker than LDL for CVD Benefits
- Approach to the Patient with Lipid Disorders
- Laboratory Assessment of Lipoproteins: Principles and Pitfalls
- Statins Diabetogenicity: Are All Same?
- Section 3: Therapeutic Lipidology
- The Effects of Diet and Exercise in Hyperlipidemia
- NAFLD: The Lipid Disease of the Liver and the Effect of Lipid-lowering Drugs
- Beyond Statins: Who and When to Prescribe?
- Role of TG-lowering Drugs on Cardiovascular Outcomes: Focus on OM3FA
- HDL-targeted Therapies: Progress and Future
- Statin Intolerance: Impact on Statin Therapy - Assessment and Management
- Diabetic Dyslipidemia: Current Concept and Guidelines
- Comparative Analysis of Major Cholesterol Guidelines: Endocrinologists’ Perspective
- International Lipid Guidelines: Implications for Indian Patients: A Cardiologist’s Viewpoint
- Lipoprotein Apheresis
- Evolving Targets of Therapies: PCSK9 and Beyond
- Section 4: Dyslipidemia in Special Population
- Lipid Management in Chronic Kidney Disease
- Dyslipidemia in Children and Adolescents: Screening, Diagnosis and Management
- Dyslipidemia in Pregnancy
- Drug Treatment of Dyslipidemia in Older Adults
- Dyslipidemia in HIV
